Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Board Gives Preliminary Nod To Voluntary DTC Guidelines

This article was originally published in The Pink Sheet Daily

Executive Summary

Companies should promote health and disease awareness as part of their advertising, the voluntary guidelines state. The principles also call for physician education prior to a DTC campaign launch, as well as targeting TV commercials for “audience and age appropriateness.” PhRMA is working out final details on specific language.

You may also be interested in...



Ball Drops On Pfizer's New Year's Eve-Themed Ads For Viagra

AIDS Healthcare Foundation urges Pfizer to curb "irresponsible" advertising for its erectile dysfunction drug.

Ball Drops On Pfizer's New Year's Eve-Themed Ads For Viagra

AIDS Healthcare Foundation urges Pfizer to curb "irresponsible" advertising for its erectile dysfunction drug.

PhRMA DTC Principles Call For End Of Reminder Ads

Independent review panel will be established to handle complaints about pharmaceutical advertising.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062607

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel